 | • レポートコード：MRC2-11QY10682 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は足白癬治療のグローバル市場について調査・分析したレポートです。種類別（インターデジタル、ベシクル）市場規模、用途別（病院薬局、小売薬局、オンライン薬局、ドラッグストア、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別足白癬治療の競争状況、市場シェア ・世界の足白癬治療市場：種類別市場規模 2015年-2020年（インターデジタル、ベシクル） ・世界の足白癬治療市場：種類別市場規模予測 2021年-2026年（インターデジタル、ベシクル） ・世界の足白癬治療市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、オンライン薬局、ドラッグストア、その他） ・世界の足白癬治療市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、オンライン薬局、ドラッグストア、その他） ・北米の足白癬治療市場分析：米国、カナダ ・ヨーロッパの足白癬治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの足白癬治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の足白癬治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの足白癬治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：GSK、Exeltis USA、Valeant、Incyte、Celgene、Hisamitsu Pharmaceutical、NovaBiotics、Elorac、F. Hoffmann-La Roche、Sanofi、Teva Pharmaceutical ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Tinea infections are fungal infections caused by T rubrum, Trichophyton mentagrophytes and Epidermophyton floccosum. This dermatophyte fungus thrives in humid conditions. The clinical features of tinea pedis include patchy and dry scaling on foot and presence of blisters or pustules on feet and between toes.
The rising prevalence of diabetes that is fueling the incidence of tinea pedis is one of the primary growth factors for this market. There is an increased prevalence of diabetes across the globe due to high levels of sugar in the blood streams and this results in numerous health issues. Diabetes reduces the quality of life, increases the risk of obesity, and early death. People with diabetes tend to be more resistant to antifungal treatment regimens due to high blood glucose levels which increases the chances of fungal growth. Consequently, diabetes patients tend to have a high risk of foot ulcerations and infections that can lead to tinea pedis or onychomycosis resulting in the need for the effective treatment of this infection.
Market Analysis and Insights: Global Tinea Pedis Treatment Market
The global Tinea Pedis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Tinea Pedis Treatment Scope and Market Size
Tinea Pedis Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Tinea Pedis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Tinea Pedis Treatment market is segmented into
Interdigital
Vesicular
Segment by Application, the Tinea Pedis Treatment market is segmented into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores
Others
Regional and Country-level Analysis
The Tinea Pedis Treatment market is analysed and market size information is provided by regions (countries).
The key regions covered in the Tinea Pedis Treatment market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Tinea Pedis Treatment Market Share Analysis
Tinea Pedis Treatment market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Tinea Pedis Treatment business, the date to enter into the Tinea Pedis Treatment market, Tinea Pedis Treatment product introduction, recent developments, etc.
The major vendors covered:
GSK
Exeltis USA
Valeant
Incyte
Celgene
Hisamitsu Pharmaceutical
NovaBiotics
Elorac
F. Hoffmann-La Roche
Sanofi
Teva Pharmaceutical
1 Study Coverage
1.1 Tinea Pedis Treatment Product Introduction
1.2 Market Segments
1.3 Key Tinea Pedis Treatment Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Tinea Pedis Treatment Market Size Growth Rate by Type
1.4.2 Interdigital
1.4.3 Vesicular
1.5 Market by Application
1.5.1 Global Tinea Pedis Treatment Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.5.5 Drug Stores
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Tinea Pedis Treatment Market Size, Estimates and Forecasts
2.1.1 Global Tinea Pedis Treatment Revenue 2015-2026
2.1.2 Global Tinea Pedis Treatment Sales 2015-2026
2.2 Global Tinea Pedis Treatment, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Tinea Pedis Treatment Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Tinea Pedis Treatment Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Tinea Pedis Treatment Competitor Landscape by Players
3.1 Tinea Pedis Treatment Sales by Manufacturers
3.1.1 Tinea Pedis Treatment Sales by Manufacturers (2015-2020)
3.1.2 Tinea Pedis Treatment Sales Market Share by Manufacturers (2015-2020)
3.2 Tinea Pedis Treatment Revenue by Manufacturers
3.2.1 Tinea Pedis Treatment Revenue by Manufacturers (2015-2020)
3.2.2 Tinea Pedis Treatment Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Tinea Pedis Treatment Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Tinea Pedis Treatment Revenue in 2019
3.2.5 Global Tinea Pedis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Tinea Pedis Treatment Price by Manufacturers
3.4 Tinea Pedis Treatment Manufacturing Base Distribution, Product Types
3.4.1 Tinea Pedis Treatment Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Tinea Pedis Treatment Product Type
3.4.3 Date of International Manufacturers Enter into Tinea Pedis Treatment Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Tinea Pedis Treatment Market Size by Type (2015-2020)
4.1.1 Global Tinea Pedis Treatment Sales by Type (2015-2020)
4.1.2 Global Tinea Pedis Treatment Revenue by Type (2015-2020)
4.1.3 Tinea Pedis Treatment Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Tinea Pedis Treatment Market Size Forecast by Type (2021-2026)
4.2.1 Global Tinea Pedis Treatment Sales Forecast by Type (2021-2026)
4.2.2 Global Tinea Pedis Treatment Revenue Forecast by Type (2021-2026)
4.2.3 Tinea Pedis Treatment Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Tinea Pedis Treatment Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Tinea Pedis Treatment Market Size by Application (2015-2020)
5.1.1 Global Tinea Pedis Treatment Sales by Application (2015-2020)
5.1.2 Global Tinea Pedis Treatment Revenue by Application (2015-2020)
5.1.3 Tinea Pedis Treatment Price by Application (2015-2020)
5.2 Tinea Pedis Treatment Market Size Forecast by Application (2021-2026)
5.2.1 Global Tinea Pedis Treatment Sales Forecast by Application (2021-2026)
5.2.2 Global Tinea Pedis Treatment Revenue Forecast by Application (2021-2026)
5.2.3 Global Tinea Pedis Treatment Price Forecast by Application (2021-2026)
6 North America
6.1 North America Tinea Pedis Treatment by Country
6.1.1 North America Tinea Pedis Treatment Sales by Country
6.1.2 North America Tinea Pedis Treatment Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Tinea Pedis Treatment Market Facts & Figures by Type
6.3 North America Tinea Pedis Treatment Market Facts & Figures by Application
7 Europe
7.1 Europe Tinea Pedis Treatment by Country
7.1.1 Europe Tinea Pedis Treatment Sales by Country
7.1.2 Europe Tinea Pedis Treatment Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Tinea Pedis Treatment Market Facts & Figures by Type
7.3 Europe Tinea Pedis Treatment Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Tinea Pedis Treatment by Region
8.1.1 Asia Pacific Tinea Pedis Treatment Sales by Region
8.1.2 Asia Pacific Tinea Pedis Treatment Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Tinea Pedis Treatment Market Facts & Figures by Type
8.3 Asia Pacific Tinea Pedis Treatment Market Facts & Figures by Application
9 Latin America
9.1 Latin America Tinea Pedis Treatment by Country
9.1.1 Latin America Tinea Pedis Treatment Sales by Country
9.1.2 Latin America Tinea Pedis Treatment Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Tinea Pedis Treatment Market Facts & Figures by Type
9.3 Central & South America Tinea Pedis Treatment Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Tinea Pedis Treatment by Country
10.1.1 Middle East and Africa Tinea Pedis Treatment Sales by Country
10.1.2 Middle East and Africa Tinea Pedis Treatment Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Tinea Pedis Treatment Market Facts & Figures by Type
10.3 Middle East and Africa Tinea Pedis Treatment Market Facts & Figures by Application
11 Company Profiles
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Description and Business Overview
11.1.3 GSK Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GSK Tinea Pedis Treatment Products Offered
11.1.5 GSK Related Developments
11.2 Exeltis USA
11.2.1 Exeltis USA Corporation Information
11.2.2 Exeltis USA Description and Business Overview
11.2.3 Exeltis USA Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Exeltis USA Tinea Pedis Treatment Products Offered
11.2.5 Exeltis USA Related Developments
11.3 Valeant
11.3.1 Valeant Corporation Information
11.3.2 Valeant Description and Business Overview
11.3.3 Valeant Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Valeant Tinea Pedis Treatment Products Offered
11.3.5 Valeant Related Developments
11.4 Incyte
11.4.1 Incyte Corporation Information
11.4.2 Incyte Description and Business Overview
11.4.3 Incyte Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Incyte Tinea Pedis Treatment Products Offered
11.4.5 Incyte Related Developments
11.5 Celgene
11.5.1 Celgene Corporation Information
11.5.2 Celgene Description and Business Overview
11.5.3 Celgene Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Celgene Tinea Pedis Treatment Products Offered
11.5.5 Celgene Related Developments
11.6 Hisamitsu Pharmaceutical
11.6.1 Hisamitsu Pharmaceutical Corporation Information
11.6.2 Hisamitsu Pharmaceutical Description and Business Overview
11.6.3 Hisamitsu Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Hisamitsu Pharmaceutical Tinea Pedis Treatment Products Offered
11.6.5 Hisamitsu Pharmaceutical Related Developments
11.7 NovaBiotics
11.7.1 NovaBiotics Corporation Information
11.7.2 NovaBiotics Description and Business Overview
11.7.3 NovaBiotics Sales, Revenue and Gross Margin (2015-2020)
11.7.4 NovaBiotics Tinea Pedis Treatment Products Offered
11.7.5 NovaBiotics Related Developments
11.8 Elorac
11.8.1 Elorac Corporation Information
11.8.2 Elorac Description and Business Overview
11.8.3 Elorac Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Elorac Tinea Pedis Treatment Products Offered
11.8.5 Elorac Related Developments
11.9 F. Hoffmann-La Roche
11.9.1 F. Hoffmann-La Roche Corporation Information
11.9.2 F. Hoffmann-La Roche Description and Business Overview
11.9.3 F. Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
11.9.4 F. Hoffmann-La Roche Tinea Pedis Treatment Products Offered
11.9.5 F. Hoffmann-La Roche Related Developments
11.10 Sanofi
11.10.1 Sanofi Corporation Information
11.10.2 Sanofi Description and Business Overview
11.10.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Sanofi Tinea Pedis Treatment Products Offered
11.10.5 Sanofi Related Developments
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Description and Business Overview
11.1.3 GSK Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GSK Tinea Pedis Treatment Products Offered
11.1.5 GSK Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Tinea Pedis Treatment Market Estimates and Projections by Region
12.1.1 Global Tinea Pedis Treatment Sales Forecast by Regions 2021-2026
12.1.2 Global Tinea Pedis Treatment Revenue Forecast by Regions 2021-2026
12.2 North America Tinea Pedis Treatment Market Size Forecast (2021-2026)
12.2.1 North America: Tinea Pedis Treatment Sales Forecast (2021-2026)
12.2.2 North America: Tinea Pedis Treatment Revenue Forecast (2021-2026)
12.2.3 North America: Tinea Pedis Treatment Market Size Forecast by Country (2021-2026)
12.3 Europe Tinea Pedis Treatment Market Size Forecast (2021-2026)
12.3.1 Europe: Tinea Pedis Treatment Sales Forecast (2021-2026)
12.3.2 Europe: Tinea Pedis Treatment Revenue Forecast (2021-2026)
12.3.3 Europe: Tinea Pedis Treatment Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Tinea Pedis Treatment Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Tinea Pedis Treatment Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Tinea Pedis Treatment Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Tinea Pedis Treatment Market Size Forecast by Region (2021-2026)
12.5 Latin America Tinea Pedis Treatment Market Size Forecast (2021-2026)
12.5.1 Latin America: Tinea Pedis Treatment Sales Forecast (2021-2026)
12.5.2 Latin America: Tinea Pedis Treatment Revenue Forecast (2021-2026)
12.5.3 Latin America: Tinea Pedis Treatment Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Tinea Pedis Treatment Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Tinea Pedis Treatment Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Tinea Pedis Treatment Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Tinea Pedis Treatment Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Tinea Pedis Treatment Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Tinea Pedis Treatment Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Tinea Pedis Treatment Market Segments
Table 2. Ranking of Global Top Tinea Pedis Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Tinea Pedis Treatment Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Interdigital
Table 5. Major Manufacturers of Vesicular
Table 6. Global Tinea Pedis Treatment Market Size Growth Rate by Application 2020-2026 (K MT)
Table 7. Global Tinea Pedis Treatment Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 8. Global Tinea Pedis Treatment Sales by Regions 2015-2020 (K MT)
Table 9. Global Tinea Pedis Treatment Sales Market Share by Regions (2015-2020)
Table 10. Global Tinea Pedis Treatment Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Tinea Pedis Treatment Sales by Manufacturers (2015-2020) (K MT)
Table 12. Global Tinea Pedis Treatment Sales Share by Manufacturers (2015-2020)
Table 13. Global Tinea Pedis Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Tinea Pedis Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tinea Pedis Treatment as of 2019)
Table 15. Tinea Pedis Treatment Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Tinea Pedis Treatment Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Tinea Pedis Treatment Price (2015-2020) (USD/MT)
Table 18. Tinea Pedis Treatment Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Tinea Pedis Treatment Product Type
Table 20. Date of International Manufacturers Enter into Tinea Pedis Treatment Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Tinea Pedis Treatment Sales by Type (2015-2020) (K MT)
Table 23. Global Tinea Pedis Treatment Sales Share by Type (2015-2020)
Table 24. Global Tinea Pedis Treatment Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Tinea Pedis Treatment Revenue Share by Type (2015-2020)
Table 26. Tinea Pedis Treatment Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 27. Global Tinea Pedis Treatment Sales by Application (2015-2020) (K MT)
Table 28. Global Tinea Pedis Treatment Sales Share by Application (2015-2020)
Table 29. North America Tinea Pedis Treatment Sales by Country (2015-2020) (K MT)
Table 30. North America Tinea Pedis Treatment Sales Market Share by Country (2015-2020)
Table 31. North America Tinea Pedis Treatment Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Tinea Pedis Treatment Revenue Market Share by Country (2015-2020)
Table 33. North America Tinea Pedis Treatment Sales by Type (2015-2020) (K MT)
Table 34. North America Tinea Pedis Treatment Sales Market Share by Type (2015-2020)
Table 35. North America Tinea Pedis Treatment Sales by Application (2015-2020) (K MT)
Table 36. North America Tinea Pedis Treatment Sales Market Share by Application (2015-2020)
Table 37. Europe Tinea Pedis Treatment Sales by Country (2015-2020) (K MT)
Table 38. Europe Tinea Pedis Treatment Sales Market Share by Country (2015-2020)
Table 39. Europe Tinea Pedis Treatment Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Tinea Pedis Treatment Revenue Market Share by Country (2015-2020)
Table 41. Europe Tinea Pedis Treatment Sales by Type (2015-2020) (K MT)
Table 42. Europe Tinea Pedis Treatment Sales Market Share by Type (2015-2020)
Table 43. Europe Tinea Pedis Treatment Sales by Application (2015-2020) (K MT)
Table 44. Europe Tinea Pedis Treatment Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Tinea Pedis Treatment Sales by Region (2015-2020) (K MT)
Table 46. Asia Pacific Tinea Pedis Treatment Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Tinea Pedis Treatment Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Tinea Pedis Treatment Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Tinea Pedis Treatment Sales by Type (2015-2020) (K MT)
Table 50. Asia Pacific Tinea Pedis Treatment Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Tinea Pedis Treatment Sales by Application (2015-2020) (K MT)
Table 52. Asia Pacific Tinea Pedis Treatment Sales Market Share by Application (2015-2020)
Table 53. Latin America Tinea Pedis Treatment Sales by Country (2015-2020) (K MT)
Table 54. Latin America Tinea Pedis Treatment Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Tinea Pedis Treatment Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Tinea Pedis Treatment Revenue Market Share by Country (2015-2020)
Table 57. Latin America Tinea Pedis Treatment Sales by Type (2015-2020) (K MT)
Table 58. Latin America Tinea Pedis Treatment Sales Market Share by Type (2015-2020)
Table 59. Latin America Tinea Pedis Treatment Sales by Application (2015-2020) (K MT)
Table 60. Latin America Tinea Pedis Treatment Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Tinea Pedis Treatment Sales by Country (2015-2020) (K MT)
Table 62. Middle East and Africa Tinea Pedis Treatment Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Tinea Pedis Treatment Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Tinea Pedis Treatment Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Tinea Pedis Treatment Sales by Type (2015-2020) (K MT)
Table 66. Middle East and Africa Tinea Pedis Treatment Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Tinea Pedis Treatment Sales by Application (2015-2020) (K MT)
Table 68. Middle East and Africa Tinea Pedis Treatment Sales Market Share by Application (2015-2020)
Table 69. GSK Corporation Information
Table 70. GSK Description and Major Businesses
Table 71. GSK Tinea Pedis Treatment Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 72. GSK Product
Table 73. GSK Recent Development
Table 74. Exeltis USA Corporation Information
Table 75. Exeltis USA Description and Major Businesses
Table 76. Exeltis USA Tinea Pedis Treatment Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Exeltis USA Product
Table 78. Exeltis USA Recent Development
Table 79. Valeant Corporation Information
Table 80. Valeant Description and Major Businesses
Table 81. Valeant Tinea Pedis Treatment Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Valeant Product
Table 83. Valeant Recent Development
Table 84. Incyte Corporation Information
Table 85. Incyte Description and Major Businesses
Table 86. Incyte Tinea Pedis Treatment Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Incyte Product
Table 88. Incyte Recent Development
Table 89. Celgene Corporation Information
Table 90. Celgene Description and Major Businesses
Table 91. Celgene Tinea Pedis Treatment Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Celgene Product
Table 93. Celgene Recent Development
Table 94. Hisamitsu Pharmaceutical Corporation Information
Table 95. Hisamitsu Pharmaceutical Description and Major Businesses
Table 96. Hisamitsu Pharmaceutical Tinea Pedis Treatment Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Hisamitsu Pharmaceutical Product
Table 98. Hisamitsu Pharmaceutical Recent Development
Table 99. NovaBiotics Corporation Information
Table 100. NovaBiotics Description and Major Businesses
Table 101. NovaBiotics Tinea Pedis Treatment Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. NovaBiotics Product
Table 103. NovaBiotics Recent Development
Table 104. Elorac Corporation Information
Table 105. Elorac Description and Major Businesses
Table 106. Elorac Tinea Pedis Treatment Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. Elorac Product
Table 108. Elorac Recent Development
Table 109. F. Hoffmann-La Roche Corporation Information
Table 110. F. Hoffmann-La Roche Description and Major Businesses
Table 111. F. Hoffmann-La Roche Tinea Pedis Treatment Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. F. Hoffmann-La Roche Product
Table 113. F. Hoffmann-La Roche Recent Development
Table 114. Sanofi Corporation Information
Table 115. Sanofi Description and Major Businesses
Table 116. Sanofi Tinea Pedis Treatment Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Sanofi Product
Table 118. Sanofi Recent Development
Table 119. Teva Pharmaceutical Corporation Information
Table 120. Teva Pharmaceutical Description and Major Businesses
Table 121. Teva Pharmaceutical Tinea Pedis Treatment Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 122. Teva Pharmaceutical Product
Table 123. Teva Pharmaceutical Recent Development
Table 124. Global Tinea Pedis Treatment Sales Forecast by Regions (2021-2026) (K MT)
Table 125. Global Tinea Pedis Treatment Sales Market Share Forecast by Regions (2021-2026)
Table 126. Global Tinea Pedis Treatment Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 127. Global Tinea Pedis Treatment Revenue Market Share Forecast by Regions (2021-2026)
Table 128. North America: Tinea Pedis Treatment Sales Forecast by Country (2021-2026) (K MT)
Table 129. North America: Tinea Pedis Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 130. Europe: Tinea Pedis Treatment Sales Forecast by Country (2021-2026) (K MT)
Table 131. Europe: Tinea Pedis Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Asia Pacific: Tinea Pedis Treatment Sales Forecast by Region (2021-2026) (K MT)
Table 133. Asia Pacific: Tinea Pedis Treatment Revenue Forecast by Region (2021-2026) (US$ Million)
Table 134. Latin America: Tinea Pedis Treatment Sales Forecast by Country (2021-2026) (K MT)
Table 135. Latin America: Tinea Pedis Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 136. Middle East and Africa: Tinea Pedis Treatment Sales Forecast by Country (2021-2026) (K MT)
Table 137. Middle East and Africa: Tinea Pedis Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 138. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 139. Key Challenges
Table 140. Market Risks
Table 141. Main Points Interviewed from Key Tinea Pedis Treatment Players
Table 142. Tinea Pedis Treatment Customers List
Table 143. Tinea Pedis Treatment Distributors List
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Tinea Pedis Treatment Product Picture
Figure 2. Global Tinea Pedis Treatment Sales Market Share by Type in 2020 & 2026
Figure 3. Interdigital Product Picture
Figure 4. Vesicular Product Picture
Figure 5. Global Tinea Pedis Treatment Sales Market Share by Application in 2020 & 2026
Figure 6. Hospital Pharmacies
Figure 7. Retail Pharmacies
Figure 8. Online Pharmacies
Figure 9. Drug Stores
Figure 10. Others
Figure 11. Tinea Pedis Treatment Report Years Considered
Figure 12. Global Tinea Pedis Treatment Market Size 2015-2026 (US$ Million)
Figure 13. Global Tinea Pedis Treatment Sales 2015-2026 (K MT)
Figure 14. Global Tinea Pedis Treatment Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Tinea Pedis Treatment Sales Market Share by Region (2015-2020)
Figure 16. Global Tinea Pedis Treatment Sales Market Share by Region in 2019
Figure 17. Global Tinea Pedis Treatment Revenue Market Share by Region (2015-2020)
Figure 18. Global Tinea Pedis Treatment Revenue Market Share by Region in 2019
Figure 19. Global Tinea Pedis Treatment Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Tinea Pedis Treatment Revenue in 2019
Figure 21. Tinea Pedis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Tinea Pedis Treatment Sales Market Share by Type (2015-2020)
Figure 23. Global Tinea Pedis Treatment Sales Market Share by Type in 2019
Figure 24. Global Tinea Pedis Treatment Revenue Market Share by Type (2015-2020)
Figure 25. Global Tinea Pedis Treatment Revenue Market Share by Type in 2019
Figure 26. Global Tinea Pedis Treatment Market Share by Price Range (2015-2020)
Figure 27. Global Tinea Pedis Treatment Sales Market Share by Application (2015-2020)
Figure 28. Global Tinea Pedis Treatment Sales Market Share by Application in 2019
Figure 29. Global Tinea Pedis Treatment Revenue Market Share by Application (2015-2020)
Figure 30. Global Tinea Pedis Treatment Revenue Market Share by Application in 2019
Figure 31. North America Tinea Pedis Treatment Sales Growth Rate 2015-2020 (K MT)
Figure 32. North America Tinea Pedis Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Tinea Pedis Treatment Sales Market Share by Country in 2019
Figure 34. North America Tinea Pedis Treatment Revenue Market Share by Country in 2019
Figure 35. U.S. Tinea Pedis Treatment Sales Growth Rate (2015-2020) (K MT)
Figure 36. U.S. Tinea Pedis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Tinea Pedis Treatment Sales Growth Rate (2015-2020) (K MT)
Figure 38. Canada Tinea Pedis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Tinea Pedis Treatment Market Share by Type in 2019
Figure 40. North America Tinea Pedis Treatment Market Share by Application in 2019
Figure 41. Europe Tinea Pedis Treatment Sales Growth Rate 2015-2020 (K MT)
Figure 42. Europe Tinea Pedis Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Tinea Pedis Treatment Sales Market Share by Country in 2019
Figure 44. Europe Tinea Pedis Treatment Revenue Market Share by Country in 2019
Figure 45. Germany Tinea Pedis Treatment Sales Growth Rate (2015-2020) (K MT)
Figure 46. Germany Tinea Pedis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Tinea Pedis Treatment Sales Growth Rate (2015-2020) (K MT)
Figure 48. France Tinea Pedis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Tinea Pedis Treatment Sales Growth Rate (2015-2020) (K MT)
Figure 50. U.K. Tinea Pedis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Tinea Pedis Treatment Sales Growth Rate (2015-2020) (K MT)
Figure 52. Italy Tinea Pedis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Tinea Pedis Treatment Sales Growth Rate (2015-2020) (K MT)
Figure 54. Russia Tinea Pedis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Tinea Pedis Treatment Market Share by Type in 2019
Figure 56. Europe Tinea Pedis Treatment Market Share by Application in 2019
Figure 57. Asia Pacific Tinea Pedis Treatment Sales Growth Rate 2015-2020 (K MT)
Figure 58. Asia Pacific Tinea Pedis Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Tinea Pedis Treatment Sales Market Share by Region in 2019
Figure 60. Asia Pacific Tinea Pedis Treatment Revenue Market Share by Region in 2019
Figure 61. China Tinea Pedis Treatment Sales Growth Rate (2015-2020) (K MT)
Figure 62. China Tinea Pedis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Tinea Pedis Treatment Sales Growth Rate (2015-2020) (K MT)
Figure 64. Japan Tinea Pedis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Tinea Pedis Treatment Sales Growth Rate (2015-2020) (K MT)
Figure 66. South Korea Tinea Pedis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Tinea Pedis Treatment Sales Growth Rate (2015-2020) (K MT)
Figure 68. India Tinea Pedis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Tinea Pedis Treatment Sales Growth Rate (2015-2020) (K MT)
Figure 70. Australia Tinea Pedis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Tinea Pedis Treatment Sales Growth Rate (2015-2020) (K MT)
Figure 72. Taiwan Tinea Pedis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Tinea Pedis Treatment Sales Growth Rate (2015-2020) (K MT)
Figure 74. Indonesia Tinea Pedis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Tinea Pedis Treatment Sales Growth Rate (2015-2020) (K MT)
Figure 76. Thailand Tinea Pedis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Tinea Pedis Treatment Sales Growth Rate (2015-2020) (K MT)
Figure 78. Malaysia Tinea Pedis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Tinea Pedis Treatment Sales Growth Rate (2015-2020) (K MT)
Figure 80. Philippines Tinea Pedis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Tinea Pedis Treatment Sales Growth Rate (2015-2020) (K MT)
Figure 82. Vietnam Tinea Pedis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Tinea Pedis Treatment Market Share by Type in 2019
Figure 84. Asia Pacific Tinea Pedis Treatment Market Share by Application in 2019
Figure 85. Latin America Tinea Pedis Treatment Sales Growth Rate 2015-2020 (K MT)
Figure 86. Latin America Tinea Pedis Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Tinea Pedis Treatment Sales Market Share by Country in 2019
Figure 88. Latin America Tinea Pedis Treatment Revenue Market Share by Country in 2019
Figure 89. Mexico Tinea Pedis Treatment Sales Growth Rate (2015-2020) (K MT)
Figure 90. Mexico Tinea Pedis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Tinea Pedis Treatment Sales Growth Rate (2015-2020) (K MT)
Figure 92. Brazil Tinea Pedis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Tinea Pedis Treatment Sales Growth Rate (2015-2020) (K MT)
Figure 94. Argentina Tinea Pedis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Tinea Pedis Treatment Market Share by Type in 2019
Figure 96. Latin America Tinea Pedis Treatment Market Share by Application in 2019
Figure 97. Middle East and Africa Tinea Pedis Treatment Sales Growth Rate 2015-2020 (K MT)
Figure 98. Middle East and Africa Tinea Pedis Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Tinea Pedis Treatment Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Tinea Pedis Treatment Revenue Market Share by Country in 2019
Figure 101. Turkey Tinea Pedis Treatment Sales Growth Rate (2015-2020) (K MT)
Figure 102. Turkey Tinea Pedis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Tinea Pedis Treatment Sales Growth Rate (2015-2020) (K MT)
Figure 104. Saudi Arabia Tinea Pedis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Tinea Pedis Treatment Sales Growth Rate (2015-2020) (K MT)
Figure 106. U.A.E Tinea Pedis Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Tinea Pedis Treatment Market Share by Type in 2019
Figure 108. Middle East and Africa Tinea Pedis Treatment Market Share by Application in 2019
Figure 109. North America Tinea Pedis Treatment Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 110. North America Tinea Pedis Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Tinea Pedis Treatment Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 112. Europe Tinea Pedis Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Tinea Pedis Treatment Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 114. Asia Pacific Tinea Pedis Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Tinea Pedis Treatment Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. Latin America Tinea Pedis Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Tinea Pedis Treatment Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 118. Middle East and Africa Tinea Pedis Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
癜風治療の世界市場（～2026年） Tinea Versicolor is one of the common types of skin infection. It also called as pityriasis versicolor. In this condition, small and discolored patches of skin occur, mostly affecting the shoulders and trunk. Market Analysis and Insights: Global Tinea Versicolor Treatment Market The global Tinea Ver…- クッシング病治療の世界市場（～2026年） Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal wit…
- 萎縮性胃炎治療の世界市場（～2026年） Atopic gastritis is chronic inflammation of gastric mucosa, and it is a histopathological condition associated with gastric glandular cell and replacement by fibrous tissue, intestinal type epithelium, and pyloric type glands. It mainly associated H. Pylori bacterial infection, and autoimmunity dire…
- ブドウ膜炎治療の世界市場（～2026年） Uveitis is considered to be the leading cause for blindness in the U.S. with a gradual rise in prevalence. North America and APAC regions expected to be major contributors in the expansion of the global uveitis treatment market. Market Analysis and Insights: Global Uveitis Treatment Market The globa…
- 尿路感染症治療の世界市場（～2026年） Urinary tract infection (UTI) is a common infections of the urinary tract, which consists of the kidneys, ureters, bladder, urethra or prostate gland. This trend of increment in the prevalence rate of diabetes among adults is expected to continue during the forecast period. Therefore, with increasin…